Larvol Delta - A-Phase-I-Safety-and-Pharmacokinetic-Study-of-Gamitrinib-Administered-Intravenously-to-Patients-With-Advanced-Cancer

gamitrinib - Fox Chase Cancer Center, The Wistar Institute

http://clinicaltrials.gov/ct2/show/NCT04827810

Jan 25, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next